Aptevo Therapeutics
APVO • NASDAQ
Aptevo Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Marvin L. White, with a market cap of $4.3M.
CEOMarvin L. White
Next Earnings
Upcoming earnings announcement for Aptevo Therapeutics
Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (8:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$1.90
Earnings History
Past 12 earnings reports for Aptevo Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | Q4 2025 | -$6.23Est: -$8.09 | +23.0% | - | — |  10-K |
| Nov 6, 2025 | Q3 2025 | -$2.23Est: -$2.09 | -6.7% | - | — | 10-Q |
| Aug 11, 2025 | Q2 2025 | -$8.40Est: -$83.20 | +89.9% | - | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$4.39Est: -$4.16 | -5.5% | - | — | 10-Q |
| Feb 15, 2025 | Q4 2024 | -$0.66Est: -$4.21 | +84.3% | - | — | 10-K |
| Nov 7, 2024 | Q3 2024 | -$17.76Est: -$123.95 | +85.7% | - | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$61.79Est: -$145.04 | +57.4% | - | — | 10-Q |
| May 8, 2024 | Q1 2024 | -$368.15Est: -$475.08 | +22.5% | - | — | 10-Q |
| Mar 5, 2024 | Q4 2023 | -$65.12Est: -$667.48 | +90.2% | - | — | 10-K |
| Nov 14, 2023 | Q3 2023 | -$814.00Est: -$1,221.00 | +33.3% | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$2,002.44Est: -$1,823.36 | -9.8% | - | — | 10-Q |
| May 11, 2023 | Q1 2023 | -$1,595.44Est: -$1,921.04 | +16.9% | - | — | — |